Abstract:Retinoid-related orphan receptor alpha (ROR alpha) and nuclear receptor subfamily 1 group D member 1 (REV-ERB alpha) play critical roles in many human cancers. Whether ROR alpha and REV-ERB alpha expression levels are associated with clinical characteristics are poorly understood, and they may be independent predictors of overall survival (OS) and progression-free survival (PFS) in gastric cancer (GC). This study aimed to investigate the correlation of ROR alpha and REV-ERB alpha expression levels with clinicopathological parameters, OS, and PFS in GC. Immunohistochemistry and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) were employed to assess the expression levels of ROR alpha and REV-ERB alpha, which were downregulated in GC tissues compared with normal gastric tissues (P<.001; P<.001) and were associated with several clinicopathological parameters, including histological grade (P=.032; P<.001), preoperative carcinoembryonic antigen (CEA) levels (P=.004; P<.001), and tumor-node-metastasis (TNM) stage (P=.015; P<.001). Additionally, low ROR alpha and REV-ERB alpha expression levels were associated with poor OS and PFS in GC patients, respectively (P<.001; P=.001). Furthermore, univariate Cox regression model analysis showed that histological grade (P<.001; P<.001), preoperative CEA levels (P<.001; P=.001), TNM stage (P<.001; P<.001), lymph node metastasis (P=.002; P=.002), ROR alpha expression levels (P=.001; P<.001), and REV-ERB alpha expression levels (P<.001; P=.001) were associated with OS and PFS in GC. Multivariate Cox regression model analysis indicated that ROR alpha expression levels and REV-ERB alpha expression levels are independent factors of OS and PFS in GC. Besides, ROR alpha and REV-ERB alpha expression may be positively correlated (chi(2)=6.835; P=.009), and GC patients with both high ROR alpha and REV-ERB alpha expression levels had the best prognosis. In conclusion, ROR alpha and REV-ERB alpha may coparticipate in tumor activities and show potential to estimate the prognosis of GC.

High Expression of C-C Chemokine Receptor 2 Associates with Poor Overall Survival in Gastric Cancer Patients after Surgical Resection

The Prognostic Value of CXC-chemokine Receptor 2 (CXCR2) in Gastric Cancer Patients

CXC Chemokine Receptor 1 Predicts Postoperative Prognosis and Chemotherapeutic Benefits for TNM II and III Resectable Gastric Cancer Patients.

C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer.

CCR7 Expression and Intratumoral FOXP3+ Regulatory T Cells Are Correlated with Overall Survival and Lymph Node Metastasis in Gastric Cancer.

Expression of C-X-C Chemokine Receptor Types 1/2 in Patients with Gastric Carcinoma: Clinicopathological Correlations and Significance.

Increased Expression of C-C Motif Ligand 2 Associates with Poor Prognosis in Patients with Gastric Cancer after Gastrectomy

CCL2/CCR2 Axis is Associated with Postoperative Survival and Recurrence of Patients with Non-Metastatic Clear-Cell Renal Cell Carcinoma.

CXC Chemokine Receptor 2 is Associated with Postoperative Recurrence and Survival of Patients with Non-Metastatic Clear-Cell Renal Cell Carcinoma.

High Expression of CXCR-2 Correlates with Lymph Node Metastasis and Predicts Unfavorable Prognosis in Resected Esophageal Carcinoma.

ROR alpha and REV-ERB alpha are Associated With Clinicopathological Parameters and are Independent Biomarkers of Prognosis in Gastric Cancer

Upregulated Expression of C-X-C Chemokine Receptor 4 is an Independent Prognostic Predictor for Patients with Gastric Cancer.

Upregulation Of C-X-C Chemokine Receptor Type 1 Expression Is Associated With Late-Stage Gastric Adenocarcinoma

High Expression of CXC Chemokine Receptor 6 Associates with Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma

High Expression of Chemokine CCL2 is Associated with Recurrence after Surgery in Clear-Cell Renal Cell Carcinoma

Combined Evaluation of Expression of Cxcr4 and Nrf2 as Prognostic Factor for Patients with Gastric Carcinoma.

Overexpression of CXCR2 Predicts Poor Prognosis in Patients with Colorectal Cancer.

High CXC chemokine receptor 1 level represents an independent negative prognosticator in non-metastatic clear-cell renal cell carcinoma patients.

High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma

Expression of chemokine receptor CCR7 in peripheral lymphocytes of gastric carcinoma and its clinical significance

Expression of Monocyte Chemotactic Protein-1/Ccl2 in Gastric Cancer and Its Relationship with Tumor Hypoxia